All Pathways
UrologyEmergency

Urosepsis Management (EAU 2024 + SSC 2021)

Urosepsis Management (EAU 2024 + SSC 2021): Suspected Urosepsis → ⚠️ RECOGNIZE SEPSIS - TIME CRITICAL → SSC Hour-1 Bundle - START IMMEDIATELY → Empiric ...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Suspected Urosepsis

    UTI with systemic inflammatory response

    1. Warning

      ⚠️ RECOGNIZE SEPSIS - TIME CRITICAL

      qSOFA: RR≥22, SBP≤100, altered mental status

      • qSOFA ≥2 = high mortality risk
      • SOFA score for organ dysfunction
      • Fever, rigors, flank pain, pyuria
      • Signs of shock: hypotension, tachycardia, mottling
      • Altered mental status = late sign
      • High index of suspicion in elderly/immunocompromised
      1. Action

        SSC Hour-1 Bundle - START IMMEDIATELY

        Do all within 1 hour of recognition

        • 1. Measure lactate (repeat if >2)
        • 2. Blood cultures BEFORE antibiotics
        • 3. Broad-spectrum IV antibiotics
        • 4. 30mL/kg crystalloid if hypotensive/lactate≥4
        • 5. Vasopressors if MAP<65 despite fluids
        • NEVER delay antibiotics for cultures
        1. Action

          Empiric Antibiotic Selection (EAU 2024)

          Broad coverage, adjust based on cultures

          • Community: Ceftriaxone 2g IV + Aminoglycoside
          • OR Piperacillin-tazobactam 4.5g IV q6h
          • Healthcare-associated: Add MRSA/Pseudomonas coverage
          • Carbapenem if ESBL risk or severe
          • Meropenem 1g IV q8h
          • De-escalate based on culture results
          1. Decision

            Obstructed Infected System?

            Critical decision - source control needed

            1. Warning

              ⚠️ URGENT SOURCE CONTROL

              Decompression saves lives (EAU Strong Rec)

              • Antibiotics CANNOT sterilize obstructed system
              • Must decompress to survive
              • Options: Nephrostomy tube OR Ureteral stent
              • Choice depends on patient stability and expertise
              • Do within hours, not days
              • Definitive stone treatment LATER
              1. Action

                Percutaneous Nephrostomy

                Often preferred in unstable patients

                • US or CT guided
                • Local anesthesia usually sufficient
                • Avoids general anesthesia
                • Direct decompression of renal pelvis
                • Send pus for culture
                • Higher success in dilated system
                1. Action

                  ICU-Level Care

                  For septic shock or organ dysfunction

                  • Vasopressors: Norepinephrine first-line
                  • Target MAP ≥65 mmHg
                  • Central venous access
                  • Arterial line for BP monitoring
                  • Lactate clearance as marker
                  • Consider stress-dose steroids if refractory
                  1. Action

                    Ongoing Monitoring

                    Track response to treatment

                    • Serial lactate (should decrease)
                    • Urine output (target >0.5mL/kg/hr)
                    • Mental status improvement
                    • Temperature trending down
                    • WBC and inflammatory markers
                    • Culture results - narrow antibiotics
                    1. Action

                      Definitive Treatment

                      After stabilization

                      • Stone removal once sepsis resolved
                      • Typically wait 2-4 weeks
                      • Transition to oral antibiotics
                      • Total duration: 7-14 days
                      • Address underlying cause
                      • Evaluate for structural abnormalities
                      1. Outcome

                        Outcomes

                        Mortality 20-40% if delayed treatment

                        • Early recognition + treatment: <10% mortality
                        • Delayed decompression: 20-40% mortality
                        • Key: antibiotics + source control FAST
                        • Long-term: address stone/obstruction cause
              2. Action

                Retrograde Ureteral Stent

                Alternative decompression

                • Requires cystoscopy (brief GA/sedation)
                • May not pass if stone impacted
                • Internal drainage
                • Less invasive long-term
                • Consider if stable and experienced OR
            2. Action

              Non-Obstructed Urosepsis

              Antibiotics and supportive care

              • Continue IV antibiotics
              • Aggressive fluid resuscitation
              • ICU if hemodynamically unstable
              • Look for other sources (prostatitis, abscess)
              • Renal/perinephric abscess may need drainage
              • Emphysematous pyelonephritis high mortality
        2. Action

          Urgent Imaging

          Identify obstructed system

          • CT abdomen/pelvis (non-contrast OK for obstruction)
          • US if CT not immediately available
          • Look for: hydronephrosis, stone, abscess
          • Pyonephrosis = purulent obstructed system
          • Air in collecting system concerning
          • Do NOT delay source control for imaging

Guideline Source

EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not replace ICU-level sepsis management
  • Antibiotic choice depends on local resistance patterns
  • Complex cases require multidisciplinary input
  • Does not address pediatric urosepsis
  • Immunocompromised patients may present atypically

Contraindicated Populations

pediatric_complex

Applicable Regions

USEUUKAU

AU: Australian Sepsis Network guidelines align with SSC

EU: EAU 2024 primary guideline, SSC for sepsis principles

UK: NICE Sepsis guidelines + EAU concordant

US: SSC 2021 + IDSA guidelines for antibiotic selection

Version 1Next review: 2028-01-11

Frequently Asked Questions

What is the Urosepsis Management (EAU 2024 + SSC 2021)?

The Urosepsis Management (EAU 2024 + SSC 2021) is a emergency clinical algorithm for Urology. It provides a structured decision tree to guide clinical decision-making, based on EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021.

What guideline is the Urosepsis Management (EAU 2024 + SSC 2021) based on?

This algorithm is based on EAU Guidelines on Urological Infections 2024 + Surviving Sepsis Campaign 2021 (DOI: 10.1016/j.eururo.2024.03.035).

What are the limitations of the Urosepsis Management (EAU 2024 + SSC 2021)?

Known limitations include: Does not replace ICU-level sepsis management; Antibiotic choice depends on local resistance patterns; Complex cases require multidisciplinary input; Does not address pediatric urosepsis; Immunocompromised patients may present atypically. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Urosepsis Management (EAU 2024 + SSC 2021) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free